September 10, 2019

Agenda

Agenda (PDF - 160.29 KB) (PDF - 160 KB)

Presentations

Innovation Lab Improve Cord Blood Experience & Payor Policy Highlights (PDF - 1.55 MB) (PDF - 2 MB)

Challenges Resulting from Implementing Donor Screening Recommendations to Reduce Risk of Zika Transmission: Background (PDF - 2.54 MB) (PDF - 3 MB)

Cord Blood Consultation Service (PDF - 93.51 KB) (PDF - 94 KB)

Efforts to Increase Cord Blood Utilization (PDF - 2.29 MB) (PDF - 2 MB)

The Diverse Use of Cord Blood for Hematologic & Non-Hematologic Indications (PDF - 2.09 MB) (PDF - 2 MB)

Key Takeaways Physician Cord Blood Summit (PDF - 110.86 KB) (PDF - 111 KB)

Report Overview (PDF - 2.8 MB) (PDF - 3 MB)

The Impact of Current Policies for Zika Virus Screening on Accrual to the Carolinas Cord Blood Bank (PDF - 427.28 KB) (PDF - 427 KB)

Update on the Current Status of Zika Virus Epidemiology (PDF - 229.05 KB) (PDF - 229 KB)

Impact of ZIKA virus (ZIKV) risk on public Cord Blood Banking (PDF - 1.41 MB) (PDF - 1 MB)

Screening of Cord Blood Donors for Zika Virus Infection (PDF - 2.2 MB) (PDF - 2 MB)

Meeting Summary

Meeting Summary Notes (PDF - 343.4 KB) (PDF - 343 KB)

Recommendations

Recommendation 32

Based on current data and reduction in observed and confirmed Zika infection, ACBSCT recommends that HHS review the current FDA Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components as the guidance relates to utilization of cord blood.

Accessibility Disclaimer

Persons using assistive technology may not be able to fully access information in these files. For assistance, contact comments@hrsa.gov or 888-275-4772 (TTY: 877-489-4772).